Haemonetics (HAE) Total Current Liabilities (2010 - 2026)

Haemonetics has reported Total Current Liabilities for 17 years, with the latest figure at $282.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 51.12% year-over-year to $282.6 million; the trailing twelve-month figure through Mar 2026 stood at $282.6 million (down 51.12% YoY), and the FY2026 full-year result was $282.6 million, down 51.12% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $282.6 million, down from $539.9 million in the prior quarter.
• The five-year high for Total Current Liabilities was $578.1 million in Q1 2025, with the low at $180.5 million in Q3 2022.
• Average Total Current Liabilities over 5 years is $336.1 million, with a median of $269.1 million recorded in 2023.
• Year-over-year, Total Current Liabilities soared 113.19% in 2025 and sank 51.12% in 2026.
• Tracing HAE's Total Current Liabilities over 5 years: stood at $226.9 million in 2022, then gained by 15.37% to $261.8 million in 2023, then slipped by 3.26% to $253.2 million in 2024, then soared by 113.19% to $539.9 million in 2025, then plunged by 47.65% to $282.6 million in 2026.
• The last three Total Current Liabilities figures came in at $282.6 million (Q1 2026), $539.9 million (Q4 2025), and $548.3 million (Q3 2025), per Business Quant data.

Peer Comparison